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Introduction. Mixed medullary-follicular thyroid carcinoma is an uncommon tumor that consists of both follicular and
parafollicular cells. Case. We report a 43-year-old woman with a palpable mass in the right side of the neck. Fine needle aspiration
suggested a diagnosis of high grade anaplastic carcinoma that has been associated with papillary features. Total thyroidectomy
was done in which histopathological examination showed diagnosis of medullary carcinoma. Immunohistochemical staining
was positive for chromogranin, calcitonin, and thyroglobulin in tumoral cells. Conclusion. Mixed medullary-follicular thyroid
carcinoma is a rare tumor. Diagnosis of these tumors with fine needle aspiration is very difficult and may lead to misdiagnosis.
It is necessary to correlate the cytological finding with serum calcitonin and thyroglobulin. Also immunostaining for calcitonin
and thyroglobulin confirms diagnosis.
1. Introduction
Medullary thyroid carcinoma (MTC) is a neuroendocrine
tumor that originates from parafollicular or c-cells of the
thyroid gland [1]. MTC accounts for 5–10% of all thyroid
carcinomas. A characteristic feature of this tumor is pro-
duction of calcitonin. Most MTCs (80%) are sporadic and
others (20%) are familial [2, 3]. Pfaltz et al. in 1959 reported
that MTC is a tumor with solid-nonfollicular pattern, and
it is different from other thyroid carcinomas clinically and
pathologically [4]. Also it was noted that histological appear-
ance of MTC may be atypical, and follicular structures can
be seen in it. Also it was shown that these tumors have
positive immunoreactivity for calcitonin and thyroglobulin.
Subsequently such tumors were named mixed medullary-
follicular carcinoma [4, 5].
Mixed medullary-follicular carcinoma is a rare tumor of
the thyroid. Less than 40 cases have been reported in the
literature [4–8].
The cellular origin of the mixed medullary-follicular
tumors is unknown.
Here we report a particular presentation of a mixed
medullary-follicular carcinoma in which fine needle aspi-
ration showed anaplastic carcinoma and mixed medullary-
follicular thyroid carcinoma confirmed after thyroidectomy.
2. Case
A 43-year-old woman presented with a palpable mass in the
right side of the neck, increasing in size over several months.
Physical examination revealed a 4 cm × 4 cm, well-defined
nontender nodule in right thyroidal lobe. There were no
other physical abnormalities. The patient didnot smoke. Her
family history was negative for thyroid and other endocrine
tumors. The patient had no history of neck or whole body




, and TSH were within
normal limits. Fine needle aspiration showed cells with large
nucleolus and severe pleomorphismwith combined follicular
and papillary like pattern. Pathologist suggested diagnosis of
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Figure 1: (a) A follicular structures in follicular carcinoma area
composed of tumoral cells. (b) Oval polygonal shaped tumoral cells
in medullary carcinoma area (arrow).
the high grade anaplastic carcinoma with papillary pattern.
The total thyroidectomy was performed.
Macroscopic Finding. The surgical specimen was fixed in
buffered formalin. The cut surface of thyroid gland showed
a well-defined nodule measuring 4 cm × 3 cm that was
unencapsulated. No area of necrosis and hemorrhage was
observed. An other part of thyroid gland was free of lesion.
2.1. Microscopic Finding. Several cut sections were stained
with hematoxylin and eosin. Solid nests of pleomorphic
cells with mitotic activity were seen. Histochemically, there
was no evidence of amyloid deposition by using crystal
violet (Figure 1). Immunoperoxidase stainingwas positive for
calcitonin, chromogranin, and thyroglobulin.
3. Discussion
MTC accounts for 5% to 10% of all thyroid malignancies.
It originates from the parafollicular or c-cells of the thyroid
gland. Tumoral cells typically produce calcitonin. On histo-
logical examination, MTC is composed of cells that vary in
morphologic feature and rearrangement. Round, polyhedral,
spindle shape cells were described. An amyloid stroma is
commonly present. Lymphatic and vascular invasion may
be seen. Definitive diagnosis can be confirmed by positive
immunostaining of tumor tissue for calcitonin and carci-
noembryonic antigen (CEA) [9, 10].
Mixed medullary-follicular carcinoma is composed of
neoplastic cells with combined histological and immuno-
histochemical features of both follicular and parafollicular
cells. [5–7, 11–14].The cellular origin of themixedmedullary-
follicular carcinoma is unknown, and several hypotheses
were described. One of the hypotheses explains that this
tumor might arise from the multipotent stem cells that can
be differentiated to follicular and c-cells [7, 15, 16].
An other hypothesis shows that common oncogenic
stimulus may affect both follicular and parafollicular cells
[7, 17].
Ectopic production of thyroglobulin in classical MTCs
has been described. Also, additional molecular alternation
in MTC may be involved in differentiation of MTC cells
toward a follicular phenotype. Volante et al. reported hostage
hypothesis. Neoplastic transformation of c-cells leads to the
development of MTC with entrapment of normal follicles
among cancerous cells. The microenvironment provided by
MTC cells would subsequently stimulate the proliferation of
the trapped follicular cells into the tumoral phenotype [18].
In some studies, RET protooncogene mutation might be
involved [11, 19].
Review of literature showed less than 50 cases of mixed
medullary-follicular carcinoma. These tumors usually occur
in middle age people, and initial presentation of them is
swelling of the neck. Serum calcitonin and thyroglobulin
are helpful markers in diagnosis, because calcitonin is pro-
duced from medullary component and thyroglobulin from
follicular cells. The size of this tumor usually is 1 cm to
5/5 cm.There are unifocal tumorswhilemultifocal tumors are
particularly associated with MEN type IIA. In most patients
lymph node metastasis is present at the time of diagnosis [6].
Distant metastasis can be observed frequently in lungs, liver,
mediastinum, and bone. These patients might die within 10
years after the diagnosis [6, 11].
In our case, fine needle aspiration was not capable of
diagnosing mixed medullary-follicular carcinoma. It seems
that role of fine needle aspiration in the diagnosis of this
tumor is very limited. In suspicious cases, measurement of
the serum calcitonin and thyroglobulin levels is helpful. We
should correlate cytological finding with serum calcitonin
and thyroglobulin. Also immunostaining for calcitonin and
thyroglobulin is essential for confirmation of diagnosis. In
our case immunostaining for calcitonin and thyroglobulin
was positive.
The principal treatment of mixed medullary-follicular
carcinoma is surgery, and total thyroidectomy should be
done. Radioiodine ablation is not effective in MTC, but, due
to presence of follicular component in mixed medullary-
follicular carcinoma, several studies suggested it. A precise
diagnosis of this tumor is fundamental for treatment and
follow-up [8, 20, 21].
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